Palisade Bio (PALI) Operating Expenses (2010 - 2026)

Palisade Bio (PALI) has 17 years of Operating Expenses data on file, last reported at $10.7 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 365.28% year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $26.5 million, a 96.31% increase from a year earlier, with the FY2025 full-year figure at $18.1 million, up 21.52% from the prior year.
• Operating Expenses for Q1 2026 stood at $10.7 million, up from $10.0 million in the prior quarter.
• Over the last five years, Operating Expenses for PALI reached as high as $10.7 million in Q1 2026 and fell as low as $2.3 million in Q1 2025.
• Historically, Operating Expenses has averaged $4.3 million across 5 years, with a median of $3.6 million in 2023.
• Across the five-year window, Operating Expenses sank 89.13% in 2022 and soared 365.28% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $3.8 million in 2022, then retreated by 18.04% to $3.2 million in 2023, then advanced by 7.23% to $3.4 million in 2024, then jumped by 195.12% to $10.0 million in 2025, then advanced by 7.68% to $10.7 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $10.7 million in Q1 2026, $10.0 million in Q4 2025, and $2.9 million in Q3 2025.